Cargando…

The regulatory T cells induction by epicutaneous immunotherapy is sustained and mediates long-term protection from eosinophilic disorders in peanut-sensitized mice

BACKGROUND: Allergen-specific immunotherapy favours immune deviation from a Th2 to a Th1 response and increases the number of regulatory T cells (Tregs). Epicutaneous immunotherapy (EPIT) of sensitized mice decreases the clinical and the allergen-specific Th2 responses and increases local and periph...

Descripción completa

Detalles Bibliográficos
Autores principales: Dioszeghy, V, Mondoulet, L, Dhelft, V, Ligouis, M, Puteaux, E, Dupont, C, Benhamou, P-H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4233996/
https://www.ncbi.nlm.nih.gov/pubmed/24666588
http://dx.doi.org/10.1111/cea.12312
_version_ 1782344788721270784
author Dioszeghy, V
Mondoulet, L
Dhelft, V
Ligouis, M
Puteaux, E
Dupont, C
Benhamou, P-H
author_facet Dioszeghy, V
Mondoulet, L
Dhelft, V
Ligouis, M
Puteaux, E
Dupont, C
Benhamou, P-H
author_sort Dioszeghy, V
collection PubMed
description BACKGROUND: Allergen-specific immunotherapy favours immune deviation from a Th2 to a Th1 response and increases the number of regulatory T cells (Tregs). Epicutaneous immunotherapy (EPIT) of sensitized mice decreases the clinical and the allergen-specific Th2 responses and increases local and peripheral Foxp3(+) Tregs. OBJECTIVE: To investigate the role of Tregs in EPIT and characterize their phenotype and maintenance following EPIT. METHODS: Tregs were investigated using in vivo depletion or adoptive transfer into BALB/c mice. Tregs were depleted using anti-CD25 antibody injection during EPIT, and allergen-specific responses were compared with Sham, EPIT alone and naïve mice. To demonstrate that Tregs can mediate protection by their own, and to study their maintenance following the end of EPIT, CD25(+)CD4(+) Tregs isolated from mice just after or 8 weeks after EPIT were transferred into peanut-sensitized mice. Foxp3-IRES-mRFP mice were transferred with EPIT-induced Tregs to analyse the induction of host Tregs. RESULTS: The anti-CD25 antibody injection to EPIT mice abrogated the induction of Tregs in spleen and the expression of Foxp3 in oesophagus. This resulted in levels of peanut-induced eosinophilic infiltration in oesophagus similar to Sham and significantly higher than EPIT. Whereas the transfer of Tregs from Sham-treated mice demonstrated no effect, the transfer of Tregs isolated just after EPIT prevented peanut-induced eosinophil infiltration and eotaxin expression and induced Foxp3 in oesophagus. The transfer of Tregs isolated 8 weeks after EPIT suppressed allergen-specific responses as efficiently as did Tregs isolated just after EPIT and increased spleen Foxp3(+) CD25(+) CD4(+) cells similarly. The use of reporter mice demonstrated an increase in host Tregs. CONCLUSIONS: These results confirm the Tregs-mediated mechanism of EPIT and demonstrate the persistence of efficient Tregs during a long period of time after treatment cessation. This suggests that EPIT induces long-term tolerance in peanut-sensitized mice.
format Online
Article
Text
id pubmed-4233996
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BlackWell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-42339962014-12-03 The regulatory T cells induction by epicutaneous immunotherapy is sustained and mediates long-term protection from eosinophilic disorders in peanut-sensitized mice Dioszeghy, V Mondoulet, L Dhelft, V Ligouis, M Puteaux, E Dupont, C Benhamou, P-H Clin Exp Allergy Original Articles BACKGROUND: Allergen-specific immunotherapy favours immune deviation from a Th2 to a Th1 response and increases the number of regulatory T cells (Tregs). Epicutaneous immunotherapy (EPIT) of sensitized mice decreases the clinical and the allergen-specific Th2 responses and increases local and peripheral Foxp3(+) Tregs. OBJECTIVE: To investigate the role of Tregs in EPIT and characterize their phenotype and maintenance following EPIT. METHODS: Tregs were investigated using in vivo depletion or adoptive transfer into BALB/c mice. Tregs were depleted using anti-CD25 antibody injection during EPIT, and allergen-specific responses were compared with Sham, EPIT alone and naïve mice. To demonstrate that Tregs can mediate protection by their own, and to study their maintenance following the end of EPIT, CD25(+)CD4(+) Tregs isolated from mice just after or 8 weeks after EPIT were transferred into peanut-sensitized mice. Foxp3-IRES-mRFP mice were transferred with EPIT-induced Tregs to analyse the induction of host Tregs. RESULTS: The anti-CD25 antibody injection to EPIT mice abrogated the induction of Tregs in spleen and the expression of Foxp3 in oesophagus. This resulted in levels of peanut-induced eosinophilic infiltration in oesophagus similar to Sham and significantly higher than EPIT. Whereas the transfer of Tregs from Sham-treated mice demonstrated no effect, the transfer of Tregs isolated just after EPIT prevented peanut-induced eosinophil infiltration and eotaxin expression and induced Foxp3 in oesophagus. The transfer of Tregs isolated 8 weeks after EPIT suppressed allergen-specific responses as efficiently as did Tregs isolated just after EPIT and increased spleen Foxp3(+) CD25(+) CD4(+) cells similarly. The use of reporter mice demonstrated an increase in host Tregs. CONCLUSIONS: These results confirm the Tregs-mediated mechanism of EPIT and demonstrate the persistence of efficient Tregs during a long period of time after treatment cessation. This suggests that EPIT induces long-term tolerance in peanut-sensitized mice. BlackWell Publishing Ltd 2014-01 2014-01-01 /pmc/articles/PMC4233996/ /pubmed/24666588 http://dx.doi.org/10.1111/cea.12312 Text en © 2014 DBV Technologies. Clinical & Experimental Allergy published by John Wiley & Sons Ltd. http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Dioszeghy, V
Mondoulet, L
Dhelft, V
Ligouis, M
Puteaux, E
Dupont, C
Benhamou, P-H
The regulatory T cells induction by epicutaneous immunotherapy is sustained and mediates long-term protection from eosinophilic disorders in peanut-sensitized mice
title The regulatory T cells induction by epicutaneous immunotherapy is sustained and mediates long-term protection from eosinophilic disorders in peanut-sensitized mice
title_full The regulatory T cells induction by epicutaneous immunotherapy is sustained and mediates long-term protection from eosinophilic disorders in peanut-sensitized mice
title_fullStr The regulatory T cells induction by epicutaneous immunotherapy is sustained and mediates long-term protection from eosinophilic disorders in peanut-sensitized mice
title_full_unstemmed The regulatory T cells induction by epicutaneous immunotherapy is sustained and mediates long-term protection from eosinophilic disorders in peanut-sensitized mice
title_short The regulatory T cells induction by epicutaneous immunotherapy is sustained and mediates long-term protection from eosinophilic disorders in peanut-sensitized mice
title_sort regulatory t cells induction by epicutaneous immunotherapy is sustained and mediates long-term protection from eosinophilic disorders in peanut-sensitized mice
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4233996/
https://www.ncbi.nlm.nih.gov/pubmed/24666588
http://dx.doi.org/10.1111/cea.12312
work_keys_str_mv AT dioszeghyv theregulatorytcellsinductionbyepicutaneousimmunotherapyissustainedandmediateslongtermprotectionfromeosinophilicdisordersinpeanutsensitizedmice
AT mondouletl theregulatorytcellsinductionbyepicutaneousimmunotherapyissustainedandmediateslongtermprotectionfromeosinophilicdisordersinpeanutsensitizedmice
AT dhelftv theregulatorytcellsinductionbyepicutaneousimmunotherapyissustainedandmediateslongtermprotectionfromeosinophilicdisordersinpeanutsensitizedmice
AT ligouism theregulatorytcellsinductionbyepicutaneousimmunotherapyissustainedandmediateslongtermprotectionfromeosinophilicdisordersinpeanutsensitizedmice
AT puteauxe theregulatorytcellsinductionbyepicutaneousimmunotherapyissustainedandmediateslongtermprotectionfromeosinophilicdisordersinpeanutsensitizedmice
AT dupontc theregulatorytcellsinductionbyepicutaneousimmunotherapyissustainedandmediateslongtermprotectionfromeosinophilicdisordersinpeanutsensitizedmice
AT benhamouph theregulatorytcellsinductionbyepicutaneousimmunotherapyissustainedandmediateslongtermprotectionfromeosinophilicdisordersinpeanutsensitizedmice
AT dioszeghyv regulatorytcellsinductionbyepicutaneousimmunotherapyissustainedandmediateslongtermprotectionfromeosinophilicdisordersinpeanutsensitizedmice
AT mondouletl regulatorytcellsinductionbyepicutaneousimmunotherapyissustainedandmediateslongtermprotectionfromeosinophilicdisordersinpeanutsensitizedmice
AT dhelftv regulatorytcellsinductionbyepicutaneousimmunotherapyissustainedandmediateslongtermprotectionfromeosinophilicdisordersinpeanutsensitizedmice
AT ligouism regulatorytcellsinductionbyepicutaneousimmunotherapyissustainedandmediateslongtermprotectionfromeosinophilicdisordersinpeanutsensitizedmice
AT puteauxe regulatorytcellsinductionbyepicutaneousimmunotherapyissustainedandmediateslongtermprotectionfromeosinophilicdisordersinpeanutsensitizedmice
AT dupontc regulatorytcellsinductionbyepicutaneousimmunotherapyissustainedandmediateslongtermprotectionfromeosinophilicdisordersinpeanutsensitizedmice
AT benhamouph regulatorytcellsinductionbyepicutaneousimmunotherapyissustainedandmediateslongtermprotectionfromeosinophilicdisordersinpeanutsensitizedmice